Heart valve calcification (HVC) is a common degenerative process leading to valvular heart disease (VHD), particularly aortic stenosis. The pathological process involves the active deposition of calcium in the valve tissues, leading to stiffening and functional impairment. This article reviews the current understanding of the mechanisms behind heart valve calcification and explores emerging pharmacological approaches aimed at preventing or slowing its progression.